This filing is part of the company’s quarterly result. Read the full results article, with every figure explained →
Board meeting set for 5 November 2026 results
Price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
On the reaction day the stock moved 2.1 pts more than Nifty Microcap 250 and 2.4 pts more than its Specialty Chemicals peers, over the same two closes: a difference in percentage points, not a measure of what the filing did.
Minute windows have no benchmark: there is no intraday index history to compare against.
The filing provides no consolidated figures for the latest quarter ended 30 September 2026 or its year-earlier comparison. The board will consider unaudited consolidated and standalone results for the quarter and half-year ended 30 September 2026 on 5 November 2026. The trading window remains closed until 48 hours after results are declared.
Results are pending, so shareholders cannot yet assess earnings, cash flow or financial strength. The stock may react when the results are published.
| Q2 FY27 | Q2 FY26 | Change | |
|---|---|---|---|
| Revenue | ₹17.72 Cr | ₹11.67 Cr | +51.8% |
| Operating profit | ₹1.82 Cr | ₹1.41 Cr | +28.9% |
| Profit after tax | ₹1.56 Cr | ₹1.28 Cr | +21.7% |
| EBITDA margin | 12.6% | 15.1% | −2.5 pp |
From the company's XBRL filing, not from the text above. Operating profit = profit before tax − exceptional items − other income. EBITDA = profit before tax + finance costs + depreciation − other income.